Recent Updates
Recently added Catalysts
ADMA Negative Sentiment Score: 25/100

ADMA Biologics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Thursday, October 10, 2024 2 min read
Key Takeaway: ADMA Biologics, Inc. is currently under investigation by the Portnoy Law Firm for potential securities fraud, prompting shareholders to consider legal action to recover losses. The law firm is offering complimentary case evaluations for affected investors. This investigation follows a significant drop in ADMA's share price, which fell over 18% after the company announced that CohnReznick would no longer serve as its independent registered accounting firm. The situation indicates growing concerns among investors about the company's corporate governance.

Market Sentiment Analysis

CONCERNS & RISKS

  • Investors have suffered losses due to a potential securities fraud investigation.
  • ADMA's shares dropped over 18% following the announcement of changes in their accounting firm.
  • The initiation of a class action lawsuit indicates significant investor dissatisfaction.

Full Press Release Details

Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ADMA Biologics, Inc. (“ADMA Biologics” or “the Company”) (NASDAQ: ADMA) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. ADMA Biologics investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: info@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
"Shares fell over 18% on Thursday, following the announcement that CohnReznick is no longer the independent registered public accounting firm, as indicated in the Form 10-Q filing for the quarter ending September 30."
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bars
lesley@portnoylaw.com
Attorney Advertising

Tags

Frequently Asked Questions

How can ADMA Biologics investors recover losses?

Investors can contact the Portnoy Law Firm for a free case evaluation.

What triggered the investigation into ADMA Biologics?

The investigation follows a significant drop in shares after firm changes.

Who leads the investigation into ADMA Biologics?

Attorney Lesley F. Portnoy is leading the investigation for investors.

What percentage did ADMA Biologics shares drop?

Shares fell over 18% following the accounting firm announcement.

Is contacting the Portnoy Law Firm free?

Yes, investors can contact the firm at no cost to discuss their options.

Tags: ADMA Viatris Investor Conferences Healthcare securities fraud Portnoy Law Firm investor losses CohnReznick
Last updated: Oct 10, 2024